BR9404004A - Poliptídeo isolado fragmento antigênico parte derivado ou análogo molécula de ácido nucléico método para reduzir o alastramento de um parasita helmíntico e composição de vacina - Google Patents

Poliptídeo isolado fragmento antigênico parte derivado ou análogo molécula de ácido nucléico método para reduzir o alastramento de um parasita helmíntico e composição de vacina

Info

Publication number
BR9404004A
BR9404004A BR9404004A BR9404004A BR9404004A BR 9404004 A BR9404004 A BR 9404004A BR 9404004 A BR9404004 A BR 9404004A BR 9404004 A BR9404004 A BR 9404004A BR 9404004 A BR9404004 A BR 9404004A
Authority
BR
Brazil
Prior art keywords
spread
nucleic acid
reduce
acid molecule
isolated polypeptide
Prior art date
Application number
BR9404004A
Other languages
English (en)
Portuguese (pt)
Inventor
Andrew Richard Milner
Michael Panaccio
Terence William Spithill
Gene Louis Wijffels
Original Assignee
Daratech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daratech Pty Ltd filed Critical Daratech Pty Ltd
Publication of BR9404004A publication Critical patent/BR9404004A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641Cysteine endopeptidases (3.4.22)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
BR9404004A 1993-02-05 1994-02-04 Poliptídeo isolado fragmento antigênico parte derivado ou análogo molécula de ácido nucléico método para reduzir o alastramento de um parasita helmíntico e composição de vacina BR9404004A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPL710993 1993-02-05
PCT/AU1994/000051 WO1994017820A1 (en) 1993-02-05 1994-02-04 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same

Publications (1)

Publication Number Publication Date
BR9404004A true BR9404004A (pt) 1999-05-25

Family

ID=3776688

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9404004A BR9404004A (pt) 1993-02-05 1994-02-04 Poliptídeo isolado fragmento antigênico parte derivado ou análogo molécula de ácido nucléico método para reduzir o alastramento de um parasita helmíntico e composição de vacina

Country Status (8)

Country Link
EP (1) EP0647138A4 (enExample)
JP (1) JPH07505787A (enExample)
AU (1) AU5996294A (enExample)
BR (1) BR9404004A (enExample)
CA (1) CA2126455A1 (enExample)
NO (1) NO942360L (enExample)
NZ (1) NZ261279A (enExample)
WO (1) WO1994017820A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0721466A1 (en) * 1993-09-28 1996-07-17 The University Of Melbourne Protective antigens against parasites
JP4321881B2 (ja) 1997-03-11 2009-08-26 スティヒティング ディーンスト ラントバウキュンディフ オンデルズーク 寄生虫に対する防御免疫測定法用の生体外動物もしくは攻撃モデルおよび当該方法において防御作用を示すワクチン
CA2425829A1 (en) * 2000-10-18 2002-05-16 Incyte Genomics, Inc. Proteases
HUE033623T2 (en) * 2002-09-11 2017-12-28 Genentech Inc protein purification
PL201419B1 (pl) * 2002-12-04 2009-04-30 Inst Biotechnologii I Antybiot Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina
PL196114B1 (pl) * 2002-12-31 2007-12-31 Inst Biotechnologii I Antybiot Ciałka inkluzyjne jako antygeny do doustnej immunizacji zwierząt
EP2485725A2 (en) * 2009-10-07 2012-08-15 Wyeth LLC Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
ES2525106B1 (es) * 2013-06-17 2015-09-29 Universidad De Salamanca Péptido sintético derivado de Fasciola hepatica y su uso como vacuna
GB201714057D0 (en) * 2017-09-01 2017-10-18 Univ College Dublin Nat Univ Of Ireland Dublin A fasciola hepatica antigen and vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8432401D0 (en) * 1984-12-21 1985-02-06 Bennett C E Liver fluke antigens
AU7871987A (en) * 1986-08-18 1988-03-08 Australian National University, The Helminth parasite vaccine
NZ232327A (en) * 1989-01-31 1993-02-25 Daratech Pty Ltd Vaccine for preventative treatment of liver fluke infection in ruminants comprising as an antigen glutathione-s-transferase (gst) of f. hepatica
JP2700088B2 (ja) * 1991-07-25 1998-01-19 房則 濱島 免疫抑制剤
EP0666919B1 (en) * 1992-10-21 2003-05-14 John Pius Dalton Vaccine containing a thiol protease

Also Published As

Publication number Publication date
NO942360L (no) 1994-10-05
EP0647138A4 (en) 1996-03-06
EP0647138A1 (en) 1995-04-12
NZ261279A (en) 1996-03-26
CA2126455A1 (en) 1994-08-06
AU5996294A (en) 1994-08-29
NO942360D0 (enExample) 1994-06-21
WO1994017820A1 (en) 1994-08-18
JPH07505787A (ja) 1995-06-29

Similar Documents

Publication Publication Date Title
BR8906988A (pt) Tetrapiptidio,peptidio,composicao farmaceutica,processo para uso de peptidio e reagente para diagnostico
PT90312A (pt) Processo para a preparacao de novos anticorpos recombinantes e quimericos dirigidos contra um antigenio de adenocarcinoma humano
FI912873A7 (fi) Uusi polypeptidiyhdiste ja menetelmä sen valmistamiseksi
FI980007L (fi) Zirkonioksidiin ja ceriumoksidiin perustuva koostumus, sen valmistusmenetelmä ja käyttö
FI953134L (fi) Vesiliukoisia kondensaatiotuotteita, jotka muodostuvat aminoryhmiä sisältävistä yhdisteistä ja silloitusaineista, menetelmä niiden valmistamiseksi ja niiden käyttö
BR9406566A (pt) Composição farmacêutica uso de progesterona e/ou 17 - - estradiol e processo para a fabricação de uma preparação farmacêutica
DE69518820D1 (de) Rotogranulat und Beschichtung von Acetaminophen, Pseudoephedrin, Chlorpheniramin und, gegebenenfalls, Dextromethorphan
FI904975A7 (fi) Silloitettuja vasta-aineita ja menetelmiä niiden valmistamiseksi
FI962247L (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
BR9404004A (pt) Poliptídeo isolado fragmento antigênico parte derivado ou análogo molécula de ácido nucléico método para reduzir o alastramento de um parasita helmíntico e composição de vacina
BR9106159A (pt) Polipeptideo sintetico,vacina,estojo para detectar hiv ou anticorpos contra hiv,molecula de dna,composicao farmaceutica,anticorpo ou fragmento de ligacao de antigeno do mesmo,processos de terapia ou profilaxia de infeccao hiv,de detectar hiv,de diagnosticar infeccao hiv e para a manufatura de um polipeptideo sintetico,de uma composicao farmaceutica e de um anticorpo ou fragmento de ligacao do mesmo
EE9800334A (et) Helicobacter pylor' iga seotud nukleiinhapete ja aminohapete järjestused ja nendest tuletatud vaktsiinikompositsioonid
FI904974A7 (fi) Ristisilloitettuja vasta-aineita ja menetelmiä niiden valmistamiseksi
BR9301448A (pt) Composicao e processo para sua preparacao
BR9606596A (pt) Composto processo para preparar um composto composição cosmética ou farmacéutica e uso de um composto
BR8602190A (pt) Composicao para controle de pragas e processo para controle de baratas
BR8900697A (pt) Proteina de antigeno circunsporozoitico;composicao de vacina;composicao utilizavel para o diagnostico de malaria em seres humanos;processo para a producao da proteina de antigeno circunsporozoitico;sistema de vetor baculovirus-celula de inseto
BR9708979A (pt) Complexo imunogénico utilização do mesmo vacina processo para a preparação de um complexo imunogenico e utilização de uma proteína
EP0293827A3 (en) Assay for leishmaniasis
FI964812A7 (fi) Kasvaintenhyljintäantigeenin esiastetta koodittava eristetty nukleiinihappomolekyyli ja sen käyttöjä
PT90963A (pt) Processo para a preparacao de uma sequencia de acido nucleico e/ou de um fragmento desta ultima que codifica para pelo menos uma proteina reconhecida pelos anticorpos anti-p30 de "toxoplasma gondii" e suas aplicacoes
ITMI931828A0 (it) Processo per la preparazione di pentafluoroetano
BR9711018A (pt) Processo para prepara-Æo de 6-amino-capro-nitrilina ou mistura de 6-amino-capro-nitrilina/hexa-metileno-diamina
BR9107032A (pt) Pseudoceramidas modificadas,composto,processo para sintetizar uma pseudoceramida modificada,composicao,uso e processo para o tratamento da pele,cabelo ou unhas
FI946136A7 (fi) Substituoidut bentseenisulfonyylivirtsa-aineet ja -tiovirtsa-aineet, niiden valmistusmenetelmät ja näihin yhdisteisiin perustuvien farmaseuttisten valmisteiden käyttö

Legal Events

Date Code Title Description
FA7 Application withdrawn (art. 18 par. 1 of law 5772/71) - being contrary to morals, good customs and public security, order and health